Arrowstreet Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-415,068
Closed -$21.8M 2735
2016
Q3
$21.8M Buy
+415,068
New +$21.8M 0.07% 271